DarioHealth Director Adam Stern Receives 28,000 Shares

The restricted award vests on the last day of the second-year anniversary after its grant date.

(High)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

DarioHealth Corp. director Adam K. Stern received a direct restricted share award of 28,000 common shares on September 24, 2026, bringing his directly held shares to 57,717. The award vests on the last day of the second-year anniversary after the grant date.

Separately, AKS Family Partners L.P. automatically converted 250 Series C preferred shares into 11,760 common shares at $40.40 per share and 100 Series D-2 preferred shares into 8,435 common shares at $16.60 per share on September 18, 2025. Each preferred position fell to zero.

Insights

Analyzing...

Insider Trade Summary

350 shares exercised/converted

Exercise 5 txns

Insider STERN ADAM K

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock ^F4	28,000	$0.00	$0.00
Conversion	Series C Preferred Stock ^F2	250	$1,000.00	$250K
Conversion	Series D-2 Preferred Stock ^F3	100	$1,000.00	$100K
Conversion	Common Stock ^{F1, F2}	11,760	$40.40	$475K
Conversion	Common Stock ^{F1, F3}	8,435	$16.60	$140K

Holdings After Transaction: Series C Preferred Stock — 0 contracts (Indirect, By AKS Family Partners L.P.); Series D-2 Preferred Stock — 0 contracts (Indirect, By AKS Family Partners L.P.); Common Stock — 26,341 shares (Indirect, By AKS Family Partners L.P.); Common Stock — 57,717 shares (Direct)

Footnotes (4)

F1. Pursuant to the Second Amended and Restated Certificates of Designation of Preferences, Rights and Limitations of the Series C Preferred Stock and the Series D-2 Preferred Stock filed with the Secretary of State of the State of Delaware, the mandatory conversion period of all outstanding shares of each such series was accelerated, and such shares automatically converted into shares of Common Stock effective September 18, 2025, together with all accrued and unpaid dividends, including dividend shares, subject to certain beneficial ownership limitations.
F2. AKS Family Partners L.P.'s 250 shares of Series C Preferred Stock automatically converted into 6,189 shares of Common Stock on September 18, 2025, at a conversion price of $40.40 per share. AKS Family Partners L.P. also received 5,571 shares of Common Stock in respect of accrued and unpaid dividends on the Series C Preferred Stock, for a total of 11,760 shares of Common Stock. The conversion occurred after the 20-for-1 reverse stock split effected on August 28, 2025, and all share amounts and prices are reported on a post-split basis. The Series C Preferred Stock was previously reported on the Reporting Person's Form 4 filed in September 2025 as 123,763 shares on a pre-split, as-converted basis.
F3. AKS Family Partners L.P.'s 100 shares of Series D-2 Preferred Stock automatically converted into 6,025 shares of Common Stock on September 18, 2025, at a conversion price of $16.60 per share. AKS Family Partners L.P. also received 2,410 shares of Common Stock in respect of accrued and unpaid dividends on the Series D-2 Preferred Stock, for a total of 8,435 shares of Common Stock.
F4. The restricted share award shall vest on the last day of the second-year anniversary after the grant date.

Key Figures

Restricted share award: 28,000 shares Direct common shares following award: 57,717 shares Common shares from Series C conversion: 11,760 shares +3 more

6 metrics

Restricted share award 28,000 shares Awarded to Adam K. Stern on September 24, 2026

Direct common shares following award 57,717 shares Following the September 24, 2026 award

Common shares from Series C conversion 11,760 shares AKS Family Partners L.P., September 18, 2025

Series C conversion price $40.40 per share AKS Family Partners L.P., September 18, 2025

Common shares from Series D-2 conversion 8,435 shares AKS Family Partners L.P., September 18, 2025

Series D-2 conversion price $16.60 per share AKS Family Partners L.P., September 18, 2025

Key Terms

restricted share award, mandatory conversion period, accrued and unpaid dividends, beneficial ownership limitations

4 terms

mandatory conversion period financial

"the mandatory conversion period of all outstanding shares"

accrued and unpaid dividends financial

"together with all accrued and unpaid dividends"

Accrued and unpaid dividends are dividend payments that a company has declared or owes to shareholders but has not yet actually paid out. For investors this matters because it represents cash they expect to receive—like a paycheck that’s been earned but not yet issued—and signals the company’s payment priorities and short-term cash health, which can affect shareholder returns and claims in cases like restructuring.

beneficial ownership limitations regulatory

"subject to certain beneficial ownership limitations"

Beneficial ownership limitations are rules or contractual caps that restrict how much of a company’s stock an individual or entity can be treated as owning or controlling for legal, regulatory or corporate-governance purposes. They matter to investors because such limits affect voting power, reporting obligations, takeover risk and the ability to increase a stake — like an elevator weight limit or a lane divider that prevents any one car from taking over the whole road.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How were AKS Family Partners' DRIO preferred shares converted?

AKS Family Partners L.P.'s 250 Series C Preferred Stock shares automatically converted into 6,189 common shares at $40.40 per share, plus 5,571 dividend shares, for 11,760 common shares. Its 100 Series D-2 Preferred Stock shares automatically converted into 6,025 common shares at $16.60 per share, plus 2,410 dividend shares, for 8,435 common shares, on September 18, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 09/28/2026 - 04:08 PM Accepted by SEC EDGAR 09/28/2026 - 04:07 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

STERN ADAM K

(Last)

(First)

(Middle)

322 W 57TH STREET, #33B

(Street)

NEW YORK

10019

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
DarioHealth Corp. [ DRIO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/18/2025

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	09/18/2025⁽¹⁾		C		11,760⁽²⁾	A	$40.4⁽²⁾	17,906	I	By AKS Family Partners L.P.
Common Stock	09/18/2025⁽¹⁾		C		8,435⁽³⁾	A	$16.6⁽³⁾	26,341	I	By AKS Family Partners L.P.
Common Stock	09/24/2026⁽⁴⁾		A		28,000	A	$0	57,717	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Series C Preferred Stock	$1,000	09/18/2025		C			250	02/21/2024	09/18/2025	Common Stock	11,760⁽²⁾	$1,000	0	I	By AKS Family Partners L.P.
Series D-2 Preferred Stock	$1,000	09/18/2025		C			100	04/28/2025	09/18/2025	Common Stock	8,435⁽³⁾	$1,000	0	I	By AKS Family Partners L.P.

Explanation of Responses:

1. Pursuant to the Second Amended and Restated Certificates of Designation of Preferences, Rights and Limitations of the Series C Preferred Stock and the Series D-2 Preferred Stock filed with the Secretary of State of the State of Delaware, the mandatory conversion period of all outstanding shares of each such series was accelerated, and such shares automatically converted into shares of Common Stock effective September 18, 2025, together with all accrued and unpaid dividends, including dividend shares, subject to certain beneficial ownership limitations.

2. AKS Family Partners L.P.'s 250 shares of Series C Preferred Stock automatically converted into 6,189 shares of Common Stock on September 18, 2025, at a conversion price of $40.40 per share. AKS Family Partners L.P. also received 5,571 shares of Common Stock in respect of accrued and unpaid dividends on the Series C Preferred Stock, for a total of 11,760 shares of Common Stock. The conversion occurred after the 20-for-1 reverse stock split effected on August 28, 2025, and all share amounts and prices are reported on a post-split basis. The Series C Preferred Stock was previously reported on the Reporting Person's Form 4 filed in September 2025 as 123,763 shares on a pre-split, as-converted basis.

3. AKS Family Partners L.P.'s 100 shares of Series D-2 Preferred Stock automatically converted into 6,025 shares of Common Stock on September 18, 2025, at a conversion price of $16.60 per share. AKS Family Partners L.P. also received 2,410 shares of Common Stock in respect of accrued and unpaid dividends on the Series D-2 Preferred Stock, for a total of 8,435 shares of Common Stock.

4. The restricted share award shall vest on the last day of the second-year anniversary after the grant date.

	/s/ Adam Stern	09/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR